Text Education About Cardiovascular Health and HIV (TEACH-HIV)
Recruiting
N/A
Interventional Study
HIV
Human Immunodeficiency Virus
Cardiovascular Diseases
Atherosclerosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 40 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 260 (estimated)
- Sponsor
- University of California, San Francisco · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The overall objective is to evaluate the efficacy of educational text messages to reduce cardiovascular risk among persons living with HIV (PLWH).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* HIV positive
* At least 40 years of age
* English-speaking
Exclusion Criteria:
* Existing clinical atherosclerotic cardiovascular disease (ASCVD)
* Pregnant
* Unwilling/unable to provide informed consent
* Does not own a smartphone
Contacts